SMAD2/3 has been shown to mediate extracellular matrix accumulation and fibrosis in the liver [33,47] and to regulate epithelial–mesenchymal transition (EMT) and metastasis in response to TGFβ in HCC [48]. Here, SMAD2 is linked to hepatocellular carcinoma.